Transition to drug addiction: a negative reinforcement model based on an allostatic decrease in reward function.
BACKGROUND
The transition from initial drug use to drug addiction has been proposed to result from an allostatic decrease in reward function driven by an overactivation of brain antireward processes.


OBJECTIVE
How decreased reward function explains compulsive drug use is not entirely clear at present, and is still a subject for debate.


METHODS
We present a quantitative model of cocaine self-administration that integrates pharmacokinetic, pharmacodynamic, and motivational factors to address this question. The model assumes that reward system responsivity is a homeostatically regulated process where the desired level of responsivity (called the reward set point) is initially different from the baseline level. The reduction or correction of this difference or error in reward function would drive cocaine self-administration.


RESULTS
Theoretical data obtained by computer simulation fit the experimental data obtained in animals self-administering cocaine (i.e., the within-session pattern of self-injections, the shape and curvature of the dose-injection function, the nonlinear relationship between drug intake and regulated drug effects). Importantly, simulation of an allostatic decrease in reward system responsivity exacerbates the initial error that drives self-administration, thereby increasing both the intake of, and the motivation for, the drug. This allostatic change manifests as a vertical shift in the dose-injection function similar to that seen in animals with escalating cocaine self-administration.


CONCLUSIONS
The present model provides a satisfactory explanation of escalated drug intake and suggests a novel negative reinforcement view of addiction based on an allostatic decrease in reward function.
Ahmed
Serge H
SH
Laboratoire de Neuropsychobiologie des Désadaptations, University Victor-Segalen Bordeaux2, CNRS-UMR 5541, 33076, Bordeaux, France. sahmed@lnpb.u-bordeaux2.fr
Koob
George F
GF
D000222:Adaptation, Physiological; D000465:Algorithms; D000818:Animals; D003042:Cocaine / Q000008:administration & dosage / Q000493:pharmacokinetics; D003198:Computer Simulation; D016571:Neural Networks, Computer; D012054:Reinforcement, Psychology; D012201:Reward; D012646:Self Administration; D019966:Substance-Related Disorders / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology
D003042:Cocaine
Pharmacol Biochem Behav. 1976 Jan;4(1):45-51
4818
Neuropsychopharmacology. 1991 Jan;4(1):17-26
2003866
Psychol Rev. 1950 May;57(3):173-80
15417685
Neurosci Lett. 1987 Oct 16;81(1-2):227-31
3696469
Pharmacol Biochem Behav. 1978 Mar;8(3):219-22
26063
Pharmacol Biochem Behav. 1993 Jul;45(3):539-48
8332614
J Pharmacol Exp Ther. 1979 Aug;210(2):206-14
110922
J Pharmacol Exp Ther. 1968 May;161(1):122-9
5648489
Science. 2004 Dec 10;306(5703):1944-7
15591205
Brain Res. 1999 Aug 21;839(1):85-93
10482802
Nature. 1998 May 7;393(6680):76-9
9590692
Am J Drug Alcohol Abuse. 1988;14(1):1-15
3265025
Neuron. 1996 May;16(5):893-6
8630244
J Pharmacol Exp Ther. 1994 Dec;271(3):1391-8
7996451
Int J Clin Pharmacol Ther. 1997 Oct;35(10):401-13
9352388
Drug Alcohol Depend. 1985 May;15(1-2):123-30
4017869
Science. 2004 Dec 10;306(5703):1901-2
15591193
Eur J Neurosci. 2003 Jan;17(1):191-5
12534985
Psychopharmacology (Berl). 1995 Jul;120(1):10-20
7480530
Nature. 2001 Mar 8;410(6825):277-84
11258383
Drug Metab Dispos. 2002 Mar;30(3):254-61
11854142
Psychopharmacology (Berl). 2001 Aug;157(1):31-9
11512040
Psychopharmacology (Berl). 2000 Oct;152(2):123-31
11057515
Behav Pharmacol. 1995 Jun;6(4):333-347
11224342
Psychopharmacologia. 1971;22(3):271-81
4399836
Neuroreport. 2003 Dec 2;14(17):2229-32
14625453
Psychol Rev. 1987 Oct;94(4):469-92
3317472
Psychol Rev. 1974 Mar;81(2):119-45
4817611
Neuropsychopharmacology. 2001 Feb;24(2):97-129
11120394
Psychopharmacology (Berl). 1991;105(2):169-74
1796123
Psychopharmacology (Berl). 1989;97(1):23-9
2496421
Psychopharmacology (Berl). 1979 Oct;65(2):125-36
117480
Brain Res Brain Res Rev. 2001 Oct;36(2-3):129-38
11690609
Trends Neurosci. 2001 Apr;24(4):207-11
11250003
Behav Brain Res. 1986 Jun;20(3):313-21
3488749
Behav Neurosci. 2000 Jun;114(3):468-83
10883798
Neuropsychopharmacology. 2000 Apr;22(4):413-21
10700660
Behav Pharmacol. 1995 Apr;6(3):223-228
11224330
Psychopharmacology (Berl). 2001 May;155(3):278-84
11432690
J Neurosci. 1998 Apr 15;18(8):3098-115
9526026
Psychopharmacology (Berl). 2004 Jan;171(3):349-51; author reply 352-63
14530895
Curr Opin Neurobiol. 1996 Apr;6(2):243-51
8725967
Brain Res. 1981 Mar 30;209(2):496-500
6971689
Psychopharmacology (Berl). 1995 Jan;117(2):130-6
7753958
Neuropsychopharmacology. 2003 May;28(5):919-31
12637948
J Exp Anal Behav. 1963 Jul;6:387-92
13963807
Am J Psychiatry. 2000 Nov;157(11):1789-98
11058476
FASEB J. 1988 Feb;2(2):97-107
3277888
J Pharmacol Exp Ther. 1973 Oct;187(1):27-33
4795731
Sci Am. 1982 Mar;246(3):128-41
7043731
Neuron. 2002 Oct 10;36(2):199-211
12383777
Mol Psychiatry. 2004 Jun;9(6):557-69
15098002
J Pharmacol Exp Ther. 1974 Oct;191(1):179-88
4421302
Psychopharmacology (Berl). 1993;111(2):215-8
7870955
Addiction. 2000 Aug;95 Suppl 2:S91-117
11002906
Can J Psychol. 1969 Feb;23(1):11-23
5776912
Pharmacol Biochem Behav. 1983 Sep;19(3):385-91
6634887
J Neurochem. 2003 Jul;86(1):102-13
12807430
Harv Rev Psychiatry. 1997 Jan-Feb;4(5):231-44
9385000
J Abnorm Psychol. 1981 Dec;90(6):586-600
7320328
Psychopharmacologia. 1974 Jan 14;34(3):255-64
4819978
Psychopharmacologia. 1976;46(1):19-25
1257363
Exp Clin Psychopharmacol. 2001 May;9(2):131-43
11518086
Pharmacology. 2003 May;68(1):49-56
12660479
Subst Use Misuse. 2001 Feb;36(3):237-55
11325165
Proc Natl Acad Sci U S A. 2002 Feb 19;99 Suppl 1:2466-72
11875196
Psychol Bull. 1982 Sep;92(2):367-81
7146233
Nature. 1976 Nov 4;264(5581):57-9
12471
Nature. 1997 Apr 24;386(6627):830-3
9126741
Psychopharmacology (Berl). 1999 Oct;146(3):303-12
10541731
Psychopharmacology (Berl). 1996 Jun;125(4):285-345
8826538
Life Sci. 1978 Feb;22(7):619-23
415198
Science. 1997 Oct 3;278(5335):52-8
9311926
Science. 1993 Jun 18;260(5115):1814-6
8099761
Psychiatr Q. 1952 Apr;26(2):270-93
14920640
Neuropsychopharmacology. 1996 Jun;14(6):375-424
8726752
Neurosci Biobehav Rev. 2004 Jan;27(8):827-39
15019432
J Neurochem. 1991 Apr;56(4):1299-306
2002342
Psychopharmacology (Berl). 2002 Aug;162(4):373-8
12172690
J Pharmacol Exp Ther. 1989 Oct;251(1):150-5
2529365
Psychopharmacology (Berl). 1995 Aug;120(3):296-302
8524977
Physiol Rev. 1991 Jan;71(1):155-234
1986388
Science. 1971 Sep 17;173(4002):1103-7
5098954
Behav Pharmacol. 1992 Dec;3(6):635-638
11224164
NIDA Res Monogr. 1984;50:92-110
6440028
Science. 2004 Aug 13;305(5686):1017-9
15310907
Pharmacol Biochem Behav. 1978 Apr;8(4):437-9
307772
Pharmacol Biochem Behav. 1989 Dec;34(4):899-904
2623043
Am J Psychiatry. 2003 Oct;160(10):1726-39
14514480
JAMA. 1985 Jul 5;254(1):81-3
4039767
J Pharmacol Exp Ther. 1997 Dec;283(3):1160-7
9399989
Fed Proc. 1979 Oct;38(11):2473-6
488370
Science. 1961 Sep 29;134(3483):943-4
13714876
Pharmacol Biochem Behav. 1999 Jun;63(2):301-11
10371660
Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):5880-4
7597046
Nat Neurosci. 2002 Jul;5(7):625-6
12055635
J Neurosci. 1998 Sep 15;18(18):7588-98
9736676
Annu Rev Psychol. 2004;55:431-61
14744222
Psychopharmacology (Berl). 2000 Jul;151(1):55-63
10958117
Psychopharmacologia. 1974 Jan 14;34(3):199-208
4856517
Life Sci. 1990;47(17):1501-10
2250566
Brain Res Brain Res Rev. 1998 Dec;28(3):309-69
9858756
Psychopharmacology (Berl). 1996 Jun;125(4):361-70
8826541
Psychopharmacology (Berl). 2004 Aug;175(1):26-36
15042275
Physiol Behav. 1992 Jan;51(1):111-9
1741436
Science. 1988 Nov 4;242(4879):715-23
2903550
Science. 1998 Oct 9;282(5387):298-300
9765157
Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91
8401595
Psychopharmacologia. 1969;16(1):30-48
4982648
J Neurosci. 2001 Jun 1;21(11):4074-80
11356895
Psychopharmacology (Berl). 2003 Apr;167(1):9-19
12644888
Nature. 2001 Mar 1;410(6824):35-6
11242031
Annu Rev Med. 1989;40:149-61
2658744
Pharmacol Biochem Behav. 2004 Dec;79(4):761-71
15582685
Psychopharmacology (Berl). 1993;110(1-2):5-12
7870898
Brain Res. 2004 Jan 2;995(1):46-54
14644470
Pharmacol Biochem Behav. 1999 Nov;64(3):507-12
10548263